Jason Mast
@Jasonmmast
Followers
5K
Following
10K
Media
156
Statuses
7K
Writing about science, medicine & business for @statnews Email me: [email protected]
Joined April 2012
Early-career trans researchers reconsider their futures amid lost funding and fear Part 6 in STAT's American Science, Shattered series, looking at what the Trump Administration has done to science and health in 11 months https://t.co/d5mHq1ZKpR
statnews.com
The chaos created by the freezing and termination of billions of dollars of research grants has left trans academics especially vulnerable.
0
0
2
Filed under terrifying: Sperm donor with rare cancer-causing mutation fathers nearly 200 children across Europe https://t.co/jcP2s2k50y
statnews.com
A sperm donor who carried a cancer-causing gene mutation fathered nearly 200 children, an investigation by 14 European news organizations show.
1
0
2
This piece also includes this stat about even America's allegedly "rising" rate of chronic disease
MAHA wants to tackle chronic diseases. This country had that idea decades ago A Gawande-esque look into a health system that, seemingly, has figured it out. Via @DrewQJoseph
https://t.co/LD6ypTKNbT
0
0
3
MAHA wants to tackle chronic diseases. This country had that idea decades ago A Gawande-esque look into a health system that, seemingly, has figured it out. Via @DrewQJoseph
https://t.co/LD6ypTKNbT
statnews.com
Happy 40th birthday — now come in for your health checkup. That's one way Slovenia is lowering rates of chronic disease.
0
0
3
$DYN CEO John Cox floats $1 million plus per year price for the potential DMD drug
Dyne $DYN plans to file for approval for next-generation Duchenne drug Infusion could be a more effective version of controversial Sarepta drug Exondys https://t.co/R7ysNBJDKp
1
0
3
Dyne $DYN plans to file for approval for next-generation Duchenne drug Infusion could be a more effective version of controversial Sarepta drug Exondys https://t.co/R7ysNBJDKp
statnews.com
Dyne Therapeutics plans to submit its next-gen Duchenne muscular dystrophy drug to the FDA after a successful trial.
1
1
7
Hello! If you can break away from college football for a moment... #ASH25 Day One recap $SNDX Revuforj frontline AML results $VRTX $CRSP Casgevy in young kids Star Therapeutics - Von Willebrand disease Stand up for Science buttons and a brief STAT event recap
statnews.com
At the end of a tense year for science, the American Society of Hematology heard promising data on acute myeloid leukemia, Von Willebrand disease and more.
2
4
56
RFK Jr.’s vaccine panel is laying the groundwork for more scrutiny of childhood shots https://t.co/XkUU61GqmX via @_daniel_payne @ChelseaCirruzzo
statnews.com
RFK Jr.’s vaccine panel is laying the groundwork for more scrutiny of childhood shots.
2
1
15
I've known this researcher for years and have always been impressed. This, by @angRchen, was hard to read. His lab was humming with discovery. After one year under Trump, it’s almost silent https://t.co/Cp2HHJVM1v
statnews.com
John Quackenbush built a lab that is at the forefront of human genetics research and bioinformatics. Trump administration cuts have put it in danger of collapse.
9
18
52
Hello #ASH25 attendees! STAT is hosting a free, live event tonight and you're all invited. We'll be talking about the future of hematology and oncology with execs from J&J, Bristol and Gilead Sciences. Plus, food and drinks! Details here:
statnews.com
We’re on the ground at the 67th American Society of Hematology Annual Meeting — join us live.
2
3
18
Part 4 in our American Science, Shattered series His lab was humming with discovery. After one year under Trump, it’s almost silent. John Quackenbush, computational biology pioneer, ‘knew biomedical research was in the crosshairs’ by @angRchen
https://t.co/EwjTkAtm75
statnews.com
John Quackenbush built a lab that is at the forefront of human genetics research and bioinformatics. Trump administration cuts have put it in danger of collapse.
1
3
10
76 slides! In sweeping presentation, vaccine critic set to urge government advisers to rethink childhood shots https://t.co/WWQRFtaX7L via @statnews @_daniel_payne
statnews.com
In sweeping presentation, vaccine critic urges government advisers to rethink childhood shots.
1
6
15
Vinay Prasad, the FDA official, spoke to biotech investors in a closed-door session today. But STAT's @damiangardehas the details. Prasad blamed “misleading media narratives” for the escalating criticism of his leadership amid turmoil and plummeting morale at the agency. “I
statnews.com
In a closed meeting, Vinay Prasad pushes back on criticism of his vaccine policy changes, morale issues at the FDA, and his role in recent drug-approval turbulence.
14
15
76
It's fascinating to watch, for a second time, people on this panel speak with such conviction about what needs to happen with this vaccine guidance. And then when it comes time to vote on said guidance, they don't really know what to do.
1
1
0
STAT has an amazing series running on how changes at the federal level are shattering the American scientific edifice. I was struck by this quote, from Elias Zerhouni, who has headed both the NIH and the R&D operations of Sanofi. “My fear is that they don’t even realize what
8
41
108
Starting today, STAT is launching an ambitious 10-part series examining the impact of the Trump administration's policies on science. Called American Science, Shattered, the series pulls together all that's happened in the last 10 months to show how Trump policies have rippled
18
17
112
"Trump has ‘shaken the hell’ out of the 80-year research pact between the government and universities. What now?" The first in a remarkable series looking at what the Trump Administration has done to American science and health over 11 months https://t.co/xYzsW28WV6
statnews.com
Trump has "shaken the hell" out of the 80-year research pact between the government and universities. What now?
0
3
9
BREAKING: Capricor $CAPR says its cell therapy improved heart and muscle function in Duchenne patients The dual outcomes in a Phase 3 study will likely bolster the treatment’s regulatory future https://t.co/8ql95NDbaj via @Jasonmmast and me
statnews.com
Capricor Therapeutics said Wednesday that its cell therapy significantly improved muscle and heart function in patients with Duchenne muscular dystrophy.
3
10
66
Top drug regulator Richard Pazdur set to leave FDA
statnews.com
Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, raising concerns about agency turnover.
0
0
2